MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
09 Sep 2019
539
The "2019 Chinese Medicinal Chemistry Symposium" with Nearly 4,000 Participants Successfully Concluded with Experts Comments as Follow...
SCIMEA

On August 18, hosted by the Chinese Pharmaceutical Association, organized by the State Key Laboratory of Biotherapy of Sichuan University and West China School of Pharmacy, Sichuan University, and supported by SCIMEA, the 2019 2019 Chinese Medicinal Chemistry Symposium (CMCS) & the China-Europe Medicinal Chemistry Symposium was successfully concluded.

The conference attracted more than 3,600 industry representatives including more than 10 top foreign experts of the industry, six domestic academicians, and more than 20 Yangtze River Scholars.

 

This high-level international conference on medicinal chemistry and innovative drug R&D and achievements transformation was also highly recognized by the participating experts.

 


The CMCS successfully closed in Chengdu, an unprecedentedly success!


1. Good theme: New Targets, New Technologies, New Molecular Entities.


2, High participation: More than 3,600 participants


3. Rich content in report at the main conference and sub-conferences.

 

4. The first live webcast: Over 50,000 global audience participation in the opening and closing conference reports alone. I would like to thank Professor Yang Shengyong from Sichuan University and the conference team for their hard work for the success of the conference! The conference was well organized and highly recognized by the participants.

 

——Academician of Chinese Academy of Sciences

 

Professor Jiang Hualiang

 

The economic base in Sichuan is relatively weak, but industry companies and local governments here have an open mind and wide horizon. They attach great importance to the hosting of CMCS in Chengdu. Thanks to national experts and scholars for your visit to Chengdu. Many foreign companies also actively supported and sponsored this conference. Thanks to companies and government departments that have sponsored and supported this conference! Thanks to all participants! May China's medicine and chemistry industry boom in the new era with wide benefited scope!

 

——State Key Laboratory of Biotherapy, West China Hospital, Sichuan University

 

Professor Yu Luoting

 

On Conference (I)

 

Under the warm sun and in the gentle wind,

3,000 scholars traveled southwestward and gathered in Chengdu.

Practitioners of medical and chemistry from Sichuan University spared no efforts for the meeting organization.

 

With reasonable design and high sufficiency,

Intelligent simulation and optimization stood out at the event.

With highlights one after another at the main conference.

 

On Conference (II)

 

The highlights lasted even to the evening,

With over 400 follow-up comments,

And audience crowded even outside the hall and in the corridor.

 

New and old friends enjoyed drinks together,

And medical enterprises offer their generous sponsorship to the event.

May we meet again at the conference to come in the near future.

 

Thanks to Sheng Yong and Sichuan University for their careful organization and hospitality.

 

—— Institute of Materia Medica, Chinese Academy of Medical Sciences

 

Guo Zongru, Researcher

 

Congratulations to the successful conclusion of CMCS & the China-Europe Medicinal Chemistry Symposium. Thanks to Professor Yang Shengyong's outstanding leadership and all teams involved for their efforts in the organizing of this meeting. We noticed that you didn’t stop until 2 o'clock at night, but still got up at 6:20 the next day with less than ten minutes break time due to your busy schedule. Please accept our respect and gratitude. It is encouraging to see so many young scholars attending the conference, and the reports demonstrated very outstanding achievements and won our sincere respect. It shows us that the 21st century is the century of the Chinese. In the future, the new biotech drugs will be initiated from China and continuously produced in China as well. I wish all of you success and health.

 

——Chief of R&D and Professor of Department of Pharmacy, College of Medicine, National Taiwan University

 

Professor Chen Jiwang

 

In the future, SCIMEA will cooperate with Wenjiang and Meishan Economic Development Zone to hold international biomedical summit forums and tour exhibition to promote academic exchanges and achievement transformation. Thanks for your support and concern of our conference

 


MedComm | Intermedin promotes vessel fusion by inducing VE‐cadherin accumulation at potential fusion sites and to achieve a dynamic balance between VE‐cadherin‐complex dissociation/reconstitution
SCIMEA Biological Immunotherapy Professional Committee Officially Founded
Gynecology Committee of SCIMEA Established
Molecular Biomedicine | Development of a novel TLR8 agonist for cancer immunotherapy
Joint members | Sichuan International Medical Exchange and Promotion Association & the Flower Salon of West China Second University Hospital of Sichuan University
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1